Preliminary Program
THURSDAY, SEPTEMBER 29, 2022
7:00 am - 4:00 pm
REGISTRATION DESK
Lobby Foyer
Lobby Foyer
7:00 am - 4:00 pm
SPEAKER READY ROOM
Ballroom Foyer
Ballroom Foyer
7:00 am - 8:30 am
CONTINENTAL BREAKFAST
Casco Bay
Casco Bay
7:00am - 12:30pm
EXHIBIT HALL
2:00pm - 6:00pm
Casco Bay
8:00 am - 8:15 am
INTRODUCTION & WELCOME
NH/VT Room
John D. Seigne, MD; President
New England Section of the American Urological Association
Edward M. Messing, MD
AUA President
NH/VT Room
John D. Seigne, MD; President
New England Section of the American Urological Association
Edward M. Messing, MD
AUA President
8:15 am - 9:35 am
SCIENTIFIC SESSION I: Stones / Endourology
NH/VT Room (5 minute presentation, 3 minute discussion)
Moderators: Timothy Y. Tran MD; David Wang, MD
NH/VT Room (5 minute presentation, 3 minute discussion)
Moderators: Timothy Y. Tran MD; David Wang, MD
1. Association of Topiramate Use with Current Stone Activity -- A Population Based Analysis
James M. Jones, III, BA1, Christopher C. Robertson, MD2, Vernon M. Pais, Jr., MD2.
1Geisel School of Medicine at Dartmouth, Hanover, NH, USA, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
James M. Jones, III, BA1, Christopher C. Robertson, MD2, Vernon M. Pais, Jr., MD2.
1Geisel School of Medicine at Dartmouth, Hanover, NH, USA, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
2. Contemporary Natural History of Observed Staghorn Calculi
Britney Atwater, MD, Vernon M. Pais, Jr., MD.
Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Britney Atwater, MD, Vernon M. Pais, Jr., MD.
Dartmouth-Hitchcock Medical Center, Lebanon, NH.
3. Distressed Communities with High Risk Stone Formers May Benefit More From Multidisciplinary Kidney Stone Clinic Model
Ji Whae Choi, BA1, Sai Allu, BA1, Joshua Tanzer, PhD2, Frances Kazal, BA1, Rebecca Ortiz, BA3, Philip Caffery, PhD3, Christopher Tucci, MS1, Jie Tang, MD1, Gyan Pareek, MD1, David Sobel, MD1.
1The Warren Alpert Medical School of Brown University; Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI, USA, 2Lifespan Biostatistics Epidemiology Research Design Core, Providence, RI, USA, 3Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI, USA.
Ji Whae Choi, BA1, Sai Allu, BA1, Joshua Tanzer, PhD2, Frances Kazal, BA1, Rebecca Ortiz, BA3, Philip Caffery, PhD3, Christopher Tucci, MS1, Jie Tang, MD1, Gyan Pareek, MD1, David Sobel, MD1.
1The Warren Alpert Medical School of Brown University; Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI, USA, 2Lifespan Biostatistics Epidemiology Research Design Core, Providence, RI, USA, 3Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI, USA.
4. Urinary Thiosulfate Level in Stone Forming Versus Non-Stone forming Pregnant Females
Shuo-chieh Wu, MD1, Eileen Brandes, MD1, John Asplin, MD2, Vernon Pais, MD3.
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 2LithoLink Corp, Chicago, IL, USA, 3Dartmouth-Hichcock Medical Center, Lebanon, NH, USA.
Shuo-chieh Wu, MD1, Eileen Brandes, MD1, John Asplin, MD2, Vernon Pais, MD3.
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 2LithoLink Corp, Chicago, IL, USA, 3Dartmouth-Hichcock Medical Center, Lebanon, NH, USA.
5. Differential 24h Urine Findings in Predominantly Calcium Oxalate Monohydrate Stones
Kaylee Luck, MD, MS, Meg Hanley, BS, Emily May, BS, Vernon M. Pais, Jr., MD.
Dartmouth Hitchcock, Lebanon, NH.
Kaylee Luck, MD, MS, Meg Hanley, BS, Emily May, BS, Vernon M. Pais, Jr., MD.
Dartmouth Hitchcock, Lebanon, NH.
6. Development and Utilization of a Novel EMR-Based Care Pathway for Nephrolithiasis Management in the ED
Soum D. Lokeshwar, MD, MBA, Dylan Heckscher, MD, Benjamin H. Press, MD, Syed N. Rahman, MD, Ankur U. Choksi, MD, Daniel Heacock, PA, Dinesh Singh, MD, Piruz Motamedinia, MD.
Yale University, New Haven, CT.
Soum D. Lokeshwar, MD, MBA, Dylan Heckscher, MD, Benjamin H. Press, MD, Syed N. Rahman, MD, Ankur U. Choksi, MD, Daniel Heacock, PA, Dinesh Singh, MD, Piruz Motamedinia, MD.
Yale University, New Haven, CT.
7. Obstructing Ureteral Calculi and Presumed Infection: Impact of Antimicrobial Duration and Time from Decompression to Stone Treatment in Developing Urosepsis
Ambrose Orr, MD, Mohannad Awad, MD, Kevan Sternberg, MD.
University of Vermont Medical Center, Burlington, VT.
Ambrose Orr, MD, Mohannad Awad, MD, Kevan Sternberg, MD.
University of Vermont Medical Center, Burlington, VT.
8. Perinephric Fat Stranding is Not Associated with Elevated Serum Creatinine in Patients with Acutely Obstructing Ureteral Stones
Gregory Iovanel, BS1, Britney Atwater, MD2, Christine M. Van Horn, MD1, Rachel Engelberg, MD3, Ahmed Sobieh, MBChB, PhD1, Igor Sorokin, MD1.
1UMass Chan Medical School, Worcester, MA, USA, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 3Urology Centers of Alabama, Homewood, AL, USA.
Gregory Iovanel, BS1, Britney Atwater, MD2, Christine M. Van Horn, MD1, Rachel Engelberg, MD3, Ahmed Sobieh, MBChB, PhD1, Igor Sorokin, MD1.
1UMass Chan Medical School, Worcester, MA, USA, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 3Urology Centers of Alabama, Homewood, AL, USA.
9:35 am - 10:00 am
COFFEE BREAK
Casco Bay
Casco Bay
10:00 am - 10:30 am
STATE OF THE ART LECTURE I: Efficient LASER Lithotripsy with the Equipment You Have
NH/VT Room
Khurshid Ghani, MBChB, MS, FRCS
Professor of Urology, University of Michigan, Ann Arbor, MI
NH/VT Room
Khurshid Ghani, MBChB, MS, FRCS
Professor of Urology, University of Michigan, Ann Arbor, MI
10:30 am - 11:00 am
Structural Competency for the Urologist: Diversity, Equity & Inclusion as Core Competency
NH/VT Room
Simone Thavaseelan, MD
Rhode Island Hospital, Brown University, Providence, RI.
NH/VT Room
Simone Thavaseelan, MD
Rhode Island Hospital, Brown University, Providence, RI.
11:00 am - 12:30 pm
SCIENTIFIC SESSION II: Prostate Cancer I
NH/VT Room (5 minute presentation, 3 minute discussion)
Moderators: Boris Gershman, MD; Steven Chang, MD
NH/VT Room (5 minute presentation, 3 minute discussion)
Moderators: Boris Gershman, MD; Steven Chang, MD
9. Comparing the Costs and Benefits of Open versus Robotic Simple Prostatectomy
Catherine Gu, MD, Martin Kathrins, MD, Steven Chang, MD.
Brigham and Women's, Boston, MA.
Catherine Gu, MD, Martin Kathrins, MD, Steven Chang, MD.
Brigham and Women's, Boston, MA.
10. Prostate Cancer Screening Behaviors Among U.S. Immigrants: A Cross-Sectional Analysis Using the NHIS Database
Nathaniel F. Hansen, BS1, Joshua A. Linscott, MD, PhD2, Matthew H. Hayn, MD2, Stephen T. Ryan, MD2, Jesse Sammon, DO2.
1Tufts University School of Medicine, Boston, MA, USA, 2Maine Medical Center Division of Urology, Portland, ME, USA.
Nathaniel F. Hansen, BS1, Joshua A. Linscott, MD, PhD2, Matthew H. Hayn, MD2, Stephen T. Ryan, MD2, Jesse Sammon, DO2.
1Tufts University School of Medicine, Boston, MA, USA, 2Maine Medical Center Division of Urology, Portland, ME, USA.
11. Risk Stratification Using a Polygenic Risk Score Improves PSA Screening Efficiency: An Analysis of the PCPT Cohort
Mitchell Nguyen, MD1, Stephen Ryan, MD1, Fady Ghali, MD2, Vi Nguyen, MD3, Brandie Heald, MS4, Edward D. Esplin, MD, PhD4, Michael Liss, MD5, Andrew Kader, MD, PhD3.
1Maine Health, Portland, ME, USA, 2University of Washington, Seattle, WA, USA, 3University of California San Diego, San Diego, CA, USA, 4Invitae, San Francisco, CA, USA, 5UT Health, San Antonio, TX, USA.
Mitchell Nguyen, MD1, Stephen Ryan, MD1, Fady Ghali, MD2, Vi Nguyen, MD3, Brandie Heald, MS4, Edward D. Esplin, MD, PhD4, Michael Liss, MD5, Andrew Kader, MD, PhD3.
1Maine Health, Portland, ME, USA, 2University of Washington, Seattle, WA, USA, 3University of California San Diego, San Diego, CA, USA, 4Invitae, San Francisco, CA, USA, 5UT Health, San Antonio, TX, USA.
12. Comparison of High-Resolution Micro-Ultrasound and Conventional Ultrasound in MRI-Ultrasound Fusion Biopsy for Diagnosis of Clinically Significant Prostate Cancer
Ghazal Khajir, MD, Michael S. Leapman, MD, Preston C. Sprenkle, MD, Joseph F. Renzulli, MD.
Yale School of Medicine, New Haven, CT.
Ghazal Khajir, MD, Michael S. Leapman, MD, Preston C. Sprenkle, MD, Joseph F. Renzulli, MD.
Yale School of Medicine, New Haven, CT.
13. Comparison of MRI/Ultrasound-Fusion Trans-Rectal and Trans-Perineal Biopsy in the Detection of Clinically Significant Prostate Cancer: A Non-Inferiority Study
Adam Wiggins, MD, William Faust, MD.
Lahey Hospital and Medical Center, Burlington, MA.
Adam Wiggins, MD, William Faust, MD.
Lahey Hospital and Medical Center, Burlington, MA.
14. Provider-Level and Regional Variation in Robotic-Assisted Laparoscopic Prostatectomy Volume
Jacob Abraham, Alexander Homer, Rebecca Ortiz, Faizanahmed Munshi, Elias Hyams.
Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI.
Jacob Abraham, Alexander Homer, Rebecca Ortiz, Faizanahmed Munshi, Elias Hyams.
Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI.
15. The Effect of a Bladder Peritoneal Flap on Lymphocele Formation after Robotic Radical Prostatectomy
Joseph Wagner, MD, Ilene Staff, PhD, Tara McLaughlin, PhD, Joseph Tortora, MS, Kevin Pinto, BS, Akshay Gangakhedkar, BS.
Hartford Hospital, Hartford, CT.
Joseph Wagner, MD, Ilene Staff, PhD, Tara McLaughlin, PhD, Joseph Tortora, MS, Kevin Pinto, BS, Akshay Gangakhedkar, BS.
Hartford Hospital, Hartford, CT.
16. Patient Expectations after Robot-Assisted Laparoscopic Prostatectomy
Yuchen Liu, BS & BA, Kola Olugbade, MD, Allison Kleeman, BS, Jeffrey Sun, BS, Catrina Crociani, MPH, May Jean Counsilman, MD, Andrew A. Wagner, MD, Peter Chang, MD.
Beth Israel Deaconess Medical Center, Boston, MA, USA.
Yuchen Liu, BS & BA, Kola Olugbade, MD, Allison Kleeman, BS, Jeffrey Sun, BS, Catrina Crociani, MPH, May Jean Counsilman, MD, Andrew A. Wagner, MD, Peter Chang, MD.
Beth Israel Deaconess Medical Center, Boston, MA, USA.
17. Impact of Family History and Germline Genetic Risk Variants on Long-term Outcomes of Active Surveillance-eligible Prostate Cancer (
Florian Rumpf, BS1, Anna Plym, PhD2, Jane B. Vaselkiv, MPH2, Mark A. Preston, MD, MPH3, Adam S. Kibel, MD3, Lorelei Mucci, ScD2, Keyan Salari, MD, PhD1.
1Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA, 2Harvard T.H. Chan School of Public Health, Boston, MA, USA, 3Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Florian Rumpf, BS1, Anna Plym, PhD2, Jane B. Vaselkiv, MPH2, Mark A. Preston, MD, MPH3, Adam S. Kibel, MD3, Lorelei Mucci, ScD2, Keyan Salari, MD, PhD1.
1Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA, 2Harvard T.H. Chan School of Public Health, Boston, MA, USA, 3Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
18. Overall Survival in Patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Treated with Enzalutamide + Androgen Deprivation Therapy by High or Low Disease Volume and Progression to mHSPC (M0 at diagnosis) or De Novo mHSPC (M1 at Diagnosis): Post Hoc Analysis of the Phase 3 ARCHES Trial
Andrew J. Armstrong, MD, MSc1, Taro Iguchi, MD, PhD2, Arun A. Azad, MBBS, PhD3, Russell Z. Szmulewitz, MD4, Jeffrey Holzbeierlein, MD5, Arnauld Villers, MD, PhD6, Antonio Alcaraz, MD, PhD7, Boris Alekseev, MD8, Neal D. Shore, MD9, Francisco Gomez-Veiga, MD, PhD10, Brad Rosbrook, MS11, Fabian Zohren, MD, PhD12, Shunsuke Yamada, MEng13, Gabriel P. Haas, MD14, Arnulf Stenzl, MD15.
1Duke Cancer Institute, Center for Prostate & Urologic Cancers, Durham, NC, USA, 2Department of Urology, Kanazawa Medical University, Ishikawa, Japan, 3Peter MacCallum Cancer Centre, Melbourne, Australia, 4The University of Chicago, Chicago, IL, USA, 5The University of Kansas Medical Center, Kansas City, KS, USA, 6Department of Urology, University Hospital Centre, Lille University, Lille, France, 7Department of Urology, Hospital Clinic de Barcelona, Barcelona, Spain, 8Department of Oncology, Hertzen Moscow Cancer Research Institute, Moscow, Russian Federation, 9Carolina Urologic Research Center, Myrtle Beach, SC, USA, 10Complexo Hospitalario Universitario de A Coruña, Coruña, Spain, 11Pfizer Inc., San Diego, CA, USA, 12Pfizer Inc., New York, NY, USA, 13Data Science, Astellas Pharma Inc, Northbrook, IL, USA, 14Astellas Pharma, Northbrook, IL, USA, 15Department of Urology, University Hospital, Eberhard Karls University of Tübingen, Tübingen, Germany.
Andrew J. Armstrong, MD, MSc1, Taro Iguchi, MD, PhD2, Arun A. Azad, MBBS, PhD3, Russell Z. Szmulewitz, MD4, Jeffrey Holzbeierlein, MD5, Arnauld Villers, MD, PhD6, Antonio Alcaraz, MD, PhD7, Boris Alekseev, MD8, Neal D. Shore, MD9, Francisco Gomez-Veiga, MD, PhD10, Brad Rosbrook, MS11, Fabian Zohren, MD, PhD12, Shunsuke Yamada, MEng13, Gabriel P. Haas, MD14, Arnulf Stenzl, MD15.
1Duke Cancer Institute, Center for Prostate & Urologic Cancers, Durham, NC, USA, 2Department of Urology, Kanazawa Medical University, Ishikawa, Japan, 3Peter MacCallum Cancer Centre, Melbourne, Australia, 4The University of Chicago, Chicago, IL, USA, 5The University of Kansas Medical Center, Kansas City, KS, USA, 6Department of Urology, University Hospital Centre, Lille University, Lille, France, 7Department of Urology, Hospital Clinic de Barcelona, Barcelona, Spain, 8Department of Oncology, Hertzen Moscow Cancer Research Institute, Moscow, Russian Federation, 9Carolina Urologic Research Center, Myrtle Beach, SC, USA, 10Complexo Hospitalario Universitario de A Coruña, Coruña, Spain, 11Pfizer Inc., San Diego, CA, USA, 12Pfizer Inc., New York, NY, USA, 13Data Science, Astellas Pharma Inc, Northbrook, IL, USA, 14Astellas Pharma, Northbrook, IL, USA, 15Department of Urology, University Hospital, Eberhard Karls University of Tübingen, Tübingen, Germany.
11:00 am - 12:30 pm
The Changing Picture of Urologic Work
CT/RI Room
Dr. Ian Thompson
CT/RI Room
Dr. Ian Thompson
12:30 pm - 12:45 pm
2021-2023 Wyland F. Leadbetter, MD Research Scholar Award Update (Not for CME)
NH/VT Room
Keyan Salari, MD, PhD
Homologous Recombination Deficiency as a Determinant of Prostate Cancer Progression
NH/VT Room
Keyan Salari, MD, PhD
Homologous Recombination Deficiency as a Determinant of Prostate Cancer Progression
12:45 pm - 1:00 pm
Pickup Lunch
Ballroom Foyer
Ballroom Foyer
1:00 pm - 2:00 pm
Exploring Clinical Evidence of a Treatment Option for Metastatic Castration-Sensitive Prostate Cancer (Not for CME)
Lunch Symposium sponsored by Astellas/Pfizer
NH/VT Room
Lunch Symposium sponsored by Astellas/Pfizer
NH/VT Room
1:00 pm - 2:00 pm
Discover the Impact of GEMTESA: A Selective ?3-Adrenergic Agonist for Effective OAB Treatment (Not for CME)
Lunch Symposium sponsored by Urovant
CT/RI
Lunch Symposium sponsored by Urovant
CT/RI
2:00 pm - 2:30 pm
Poster Viewing Time (Not for CME)
MA Room
MA Room
2:30 pm - 3:30 pm
CONCURRENT POSTER SESSION I
MA Room (3 minute presentation, 2 minute discussion)
Moderators: Benjamin Ristau, MD; Stephen Ryan, MD
MA Room (3 minute presentation, 2 minute discussion)
Moderators: Benjamin Ristau, MD; Stephen Ryan, MD
P1. Utilization of Telemedicine in Cancer Patients, an Analysis of the National Health Interview Survey Data in the COVID-19 era
Khalid Alkhatib, MD, Jason Qian, MD, Catherine Gu, MD, Mara Koelker, MD, Muhieddine Labban, MD, Nicola Frego, MD, Alexander P. Cole, MD, Quoc-Dien Trinh, MD.
Brigham and Women's Hospital, Boston, MA, USA.
Khalid Alkhatib, MD, Jason Qian, MD, Catherine Gu, MD, Mara Koelker, MD, Muhieddine Labban, MD, Nicola Frego, MD, Alexander P. Cole, MD, Quoc-Dien Trinh, MD.
Brigham and Women's Hospital, Boston, MA, USA.
P2. Disparities in the Attributable Bladder Cancer Risk Due to Smoking
Yuchen Liu, BS & BA1, Yuchen Zhao, BS1, Yujia Lu, BS1, Danaei Goodarz, MD, Sc.D, MS1, Boris Gershman, MD2.
1Harvard Chan School of Public Health, Boston, MA, USA, 2Beth Israel Deaconess Medical Center, Boston, MA, USA.
Yuchen Liu, BS & BA1, Yuchen Zhao, BS1, Yujia Lu, BS1, Danaei Goodarz, MD, Sc.D, MS1, Boris Gershman, MD2.
1Harvard Chan School of Public Health, Boston, MA, USA, 2Beth Israel Deaconess Medical Center, Boston, MA, USA.
P3. "Cystectomy… What Bugs You?": Creation of an Institutional Antibiogram
Erin Santos, PA, MPH1, Joshua Linscott, MD, PhD2, Jesse D. Sammon, DO3.
1Maine Medical Partners Urology, Portland, ME, USA, 2Maine Medical Center - Division of Urology, Portland, ME, USA, 3Maine Medical Center - Division of Urology & Center for Outcomes Research and Evaluation, Portland, ME, USA.
Erin Santos, PA, MPH1, Joshua Linscott, MD, PhD2, Jesse D. Sammon, DO3.
1Maine Medical Partners Urology, Portland, ME, USA, 2Maine Medical Center - Division of Urology, Portland, ME, USA, 3Maine Medical Center - Division of Urology & Center for Outcomes Research and Evaluation, Portland, ME, USA.
P4. Robotic Versus Open Radical Cystectomy for Urothelial Carcinoma of the Bladder
Joseph B. Black, MD, PHD1, Sumedh Kaul, MS1, Aaron Fleishman, MPH1, Ruslan Korets, MD1, Peter Chang, MD, MPH1, Andrew Wagner, MD1, Simon Kim, MD2, Joaquim Bellmunt, MD, PHD1, Irving Kaplan, MD1, Aria F. Olumi, MD1, Boris Gershman, MD1.
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2University of Colorado Anschutz Medical Center, Aurora, CO, USA.
Joseph B. Black, MD, PHD1, Sumedh Kaul, MS1, Aaron Fleishman, MPH1, Ruslan Korets, MD1, Peter Chang, MD, MPH1, Andrew Wagner, MD1, Simon Kim, MD2, Joaquim Bellmunt, MD, PHD1, Irving Kaplan, MD1, Aria F. Olumi, MD1, Boris Gershman, MD1.
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2University of Colorado Anschutz Medical Center, Aurora, CO, USA.
P5. Elevated CRP after Radical Cystectomy is Associated with Infectious, Wound, and Anastomotic Complications
Joshua A. Linscott, MD, PhD, Randie E. White, MD, Stephen T. Ryan, MD, Moritz H. Hansen, MD, Matthew H. Hayn, MD, Jesse D. Sammon, DO.
Maine Medical Center, Portland, ME, USA.
Joshua A. Linscott, MD, PhD, Randie E. White, MD, Stephen T. Ryan, MD, Moritz H. Hansen, MD, Matthew H. Hayn, MD, Jesse D. Sammon, DO.
Maine Medical Center, Portland, ME, USA.
P6. Short-Term Outcomes in Radical Cystectomy Patients with History of Prior Pelvic Radiation
Ikenna Madueke, MD. PhD1, Mark Preston, MD, MPH2, Timothy Clinton, MD2, Graeme Steele, MD2, Steven Chang, MD, MS2, Adam Kibel, MD2, Matthew Mossanen, MD2.
1Harvard Medical School, Boston, MA, USA, 2Brigham and Women's Hospital, Boston, MA, USA.
Ikenna Madueke, MD. PhD1, Mark Preston, MD, MPH2, Timothy Clinton, MD2, Graeme Steele, MD2, Steven Chang, MD, MS2, Adam Kibel, MD2, Matthew Mossanen, MD2.
1Harvard Medical School, Boston, MA, USA, 2Brigham and Women's Hospital, Boston, MA, USA.
P7. Early Survival Outcomes after Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer
Joshua A. Linscott, MD, PhD, Randie E. White, MD, Stephen T. Ryan, MD, Moritz H. Hansen, MD, Matthew H. Hayn, MD, Jesse D. Sammon, DO.
Maine Medical Center, Portland, ME, USA.
Joshua A. Linscott, MD, PhD, Randie E. White, MD, Stephen T. Ryan, MD, Moritz H. Hansen, MD, Matthew H. Hayn, MD, Jesse D. Sammon, DO.
Maine Medical Center, Portland, ME, USA.
P8. Safety and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy for Localized Kidney Tumors
Kendrick Yim, MD1, Daniel Cagney, MD1, Raymond Mak, MD1, Lisa Singer, MD1, Christopher Williams, MD1, Vincent D'andrea, MD1, Neil Martin, MD1, Toni Choueiri, NMD2, Steven Chang, MD1, Jonathan Leeman, MD1.
1Brigham and Women's Hospital, Boston, MA, USA, 2Dana Farber Cancer Institute, Boston, MA, USA.
Kendrick Yim, MD1, Daniel Cagney, MD1, Raymond Mak, MD1, Lisa Singer, MD1, Christopher Williams, MD1, Vincent D'andrea, MD1, Neil Martin, MD1, Toni Choueiri, NMD2, Steven Chang, MD1, Jonathan Leeman, MD1.
1Brigham and Women's Hospital, Boston, MA, USA, 2Dana Farber Cancer Institute, Boston, MA, USA.
P9. Evaluation of Artificial Intelligence Algorithm for Automated Prostate Lesion Detection and Classification on mpMRI using African American Patient Cohort
Jacob N. Bamberger, BS, John Hordines, BS, Kyra Gassmann, BS, Lulu Wei, BS, Blaine Russ, BS, Lakshay Khosla, BS, Andrew Winer, MD, FACS.
SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Jacob N. Bamberger, BS, John Hordines, BS, Kyra Gassmann, BS, Lulu Wei, BS, Blaine Russ, BS, Lakshay Khosla, BS, Andrew Winer, MD, FACS.
SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
P10. Access to Definitive Treatment and Survival for Intermediate-risk and High-risk Prostate Cancer at Hospital Systems Serving Health Disparity Populations
Muhieddine Labban, MD1, David-Dan Nguyen, MD1, Logan Briggs, MD1, Alexander P. Cole, MD1, Stuart R. Lipsitz, ScD1, Hari S. Iyer, ScD2, Timothy R. Rebbeck, PhD2, Joel S. Weissman, PhD1, Toni K. Choueiri, MD2, Quoc-Dien Trinh, MD1.
1Brigham and Women's Hospital, Boston, MA, USA, 2Dana-Farber Cancer Institute, Boston, MA, USA.
Muhieddine Labban, MD1, David-Dan Nguyen, MD1, Logan Briggs, MD1, Alexander P. Cole, MD1, Stuart R. Lipsitz, ScD1, Hari S. Iyer, ScD2, Timothy R. Rebbeck, PhD2, Joel S. Weissman, PhD1, Toni K. Choueiri, MD2, Quoc-Dien Trinh, MD1.
1Brigham and Women's Hospital, Boston, MA, USA, 2Dana-Farber Cancer Institute, Boston, MA, USA.
P11. Increased Utilization of Ambulatory Robot Assisted Laparoscopic Prostatectomy during COVID-19 Pandemic: Results from a State Administrative Database
Zhiyu (Jason) Qian, MD1, Jamie Ye, MPH1, David Friedlander, MD2, Mara Koelker, MD1, Muhieddine Labban, MD1, Quoc-Dien Trinh, MD1, Alexander Putnam Cole, MD1.
1Brigham and Women's Hospital, Boston, MA, USA, 2University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Zhiyu (Jason) Qian, MD1, Jamie Ye, MPH1, David Friedlander, MD2, Mara Koelker, MD1, Muhieddine Labban, MD1, Quoc-Dien Trinh, MD1, Alexander Putnam Cole, MD1.
1Brigham and Women's Hospital, Boston, MA, USA, 2University of North Carolina School of Medicine, Chapel Hill, NC, USA.
2:30 pm - 3:30 pm
SCIENTIFIC SESSION III: Trauma, Recon, Female Urology and Transgender
NH/VT Room (5 minute presentation, 3 minute discussion)
Moderators: Madeline Cancian, MD; Khushabu D. Kasabwala, MD
NH/VT Room (5 minute presentation, 3 minute discussion)
Moderators: Madeline Cancian, MD; Khushabu D. Kasabwala, MD
19. Efficacy and Safety of a Novel Gene Therapy (URO-902; pVAX/hSlo) in Female Patients With Overactive Bladder and Urge Urinary Incontinence: Results From a Phase 2a Trial
Hanh Badger, PharmD1, Kenneth M. Peters, MD2, Ekene A. Enemchukwu, MD, MPH3, Susan Kalota, MD4, Kaiser Robertson, MD5, Heather Greene, MPH1, Salim Mujais, MD1, Cornelia Haag-Molkenteller, MD, PhD1.
1Urovant Sciences, Irvine, CA, USA, 2Oakland University William Beaumont School of Medicine, Rochester, MI, USA, 3Stanford University School of Medicine, Stanford, CA, USA, 4Urologic Associates of Southern Arizona, Tucson, AZ, USA, 5Chesapeake Urology, Hanover, MD, USA.
Hanh Badger, PharmD1, Kenneth M. Peters, MD2, Ekene A. Enemchukwu, MD, MPH3, Susan Kalota, MD4, Kaiser Robertson, MD5, Heather Greene, MPH1, Salim Mujais, MD1, Cornelia Haag-Molkenteller, MD, PhD1.
1Urovant Sciences, Irvine, CA, USA, 2Oakland University William Beaumont School of Medicine, Rochester, MI, USA, 3Stanford University School of Medicine, Stanford, CA, USA, 4Urologic Associates of Southern Arizona, Tucson, AZ, USA, 5Chesapeake Urology, Hanover, MD, USA.
20. Trauma History in Chronic Pain Syndromes
Caitlyn Desir, MD, Sanchita Bose, MD.
Maine Medical Center, Portland, ME.
Caitlyn Desir, MD, Sanchita Bose, MD.
Maine Medical Center, Portland, ME.
21. Comparing OnabotulinumtoxinA Injections and Sacral Neuromodulation for Treatment of Overactive Bladder
Daisy S. Chen, MS1, Esther L. Finney, MD2, Amanda L. Pomeroy, MS1, Shravya K. Sakunala, BS1, Arthur P. Mourtzinos, MD2, Lara S. MacLachlan, MD2.
1Tufts University School of Medicine, Boston, MA, USA, 2Lahey Hospital and Medical Center Department of Urology, Burlington, MA, USA.
Daisy S. Chen, MS1, Esther L. Finney, MD2, Amanda L. Pomeroy, MS1, Shravya K. Sakunala, BS1, Arthur P. Mourtzinos, MD2, Lara S. MacLachlan, MD2.
1Tufts University School of Medicine, Boston, MA, USA, 2Lahey Hospital and Medical Center Department of Urology, Burlington, MA, USA.
22. Trends in Urinary Retention Requiring Catheterization Following OnabotulinumtoxinA Treatment for Non-Neurogenic Overactive Bladder
Shravya K. Sakunala, BS1, Esther L. Finney, MD2, Amanda L. Pomeroy, MS1, Daisy S. Chen, MS1, Arthur P. Mourtzinos, MD2, Lara S. MacLachlan, MD2.
1Tufts University School of Medicine, Boston, MA, USA, 2Lahey Hospital & Medical Center, Burlington, MA, USA.
Shravya K. Sakunala, BS1, Esther L. Finney, MD2, Amanda L. Pomeroy, MS1, Daisy S. Chen, MS1, Arthur P. Mourtzinos, MD2, Lara S. MacLachlan, MD2.
1Tufts University School of Medicine, Boston, MA, USA, 2Lahey Hospital & Medical Center, Burlington, MA, USA.
23. Residency Applicant Demographics and Their Association with Rank-List Status: A Seven-Year Analysis of a Single Institution's Diversity, Equity, and Inclusion Initiatives in Recruitment (
Joshua P. Hayden, MD, Adam Wiggins, MD, Lara S. MacLachlan, MD, Karim Hamawy, MD.
Lahey Hospital and Medical Center, Burlington, MA.
Joshua P. Hayden, MD, Adam Wiggins, MD, Lara S. MacLachlan, MD, Karim Hamawy, MD.
Lahey Hospital and Medical Center, Burlington, MA.
24. Evaluating Video Quality, Understandability, and Actionability of YouTube Content for Gender Affirming Surgery: Metoidioplasty
Reade Otto-Moudry, BA2, Alexandra E. Hunter, BA1, Cynthia Yusuf, BS3, Rena D. Malik, MD4, Rachel A. Moses, MD, MPH1.
1Dartmouth Hitchcock Medical Center, Lebanon, NH, USA, 2Geisel School of Medicine at Dartmouth, Hanover, NH, USA, 3University of Maryland School of Medicine, Baltimore, DC, USA, 4University of Maryland Medical Health System, Baltimore, DC, USA.
Reade Otto-Moudry, BA2, Alexandra E. Hunter, BA1, Cynthia Yusuf, BS3, Rena D. Malik, MD4, Rachel A. Moses, MD, MPH1.
1Dartmouth Hitchcock Medical Center, Lebanon, NH, USA, 2Geisel School of Medicine at Dartmouth, Hanover, NH, USA, 3University of Maryland School of Medicine, Baltimore, DC, USA, 4University of Maryland Medical Health System, Baltimore, DC, USA.
25. The Artificial Urinary Sphincter and the Octogenarian
Siddharth Marthi, MD, Rachel Greenberg, MD, Aparna Ashok, MD, Kennon Miller, MD, Madeline Cancian, MD.
The Warren Alpert Medical School of Brown University, Providence, RI.
Siddharth Marthi, MD, Rachel Greenberg, MD, Aparna Ashok, MD, Kennon Miller, MD, Madeline Cancian, MD.
The Warren Alpert Medical School of Brown University, Providence, RI.
3:30 pm - 4:00 pm
EDUCATIONAL PANEL: Conflict Resolution & Un-Professionalism in a Residency Training Environment
NH/VT Room
NH/VT Room
| Moderator: | Aria Olumi, MD |
| Panelists: | Ruslan Korets, MD Beth Israel Deaconess Medical Center, Boston, MA Adam B. Hittelman, MD, PhD Yale School of Medicine, New Haven, CT Simone Thavaseelan, MD Rhode Island Hospital/Brown University, Providence, RI |
4:00 pm - 6:00 pm
Welcome Reception in Exhibit Hall
Casco Bay
Casco Bay
FRIDAY, SEPTEMBER 30, 2022
7:30 am - 6:00 pm
REGISTRATION DESK
Lobby Foyer
Lobby Foyer
7:30 am - 6:00 pm
SPEAKER READY ROOM
Ballroom Foyer
Ballroom Foyer
7:30 am - 8:30 am
CONTINENTAL BREAKFAST
Casco Bay
Casco Bay
7:30 am - 12:30 pm
EXHIBIT HALL
2:00 pm - 7:30pm
Casco Bay
8:00 am - 12:00 pm
HOSPITALITY SUITE
York Room
York Room
8:00 am - 9:00 am
INTERNATIONAL PANEL on NMIBC
NH/VT Room
NH/VT Room
| Moderators: | Mark A. Preston, MD; Jennifer Yates, MD; Matthew Hayn, MD |
| Panelists: | Thomas Seisen, MD Pitié Salpêtrière Hospital, Paris, France Murilo Luz, MD Beneficência Portuguesa de São Saulo, Brazil Craig Hawkins, MD Mid Coast Hospital, Maine Health, Brunswick, ME Rodney Breau, MD The Ottawa Hospital, Ottawa, Canada Anita Clarke, MD St Vincent's Health, Melbourne, Australia Raghunath SK, MD Trustwell Hospital, Bengaluru India |
9:00 am - 10:30 am
CONCURRENT SCIENTIFIC SESSION IV: General/BPH
NH/VT Room (5 minute presentation, 3 minute discussion)
Moderators: Shaun Wason, MD; Jared Bieniek, MD
NH/VT Room (5 minute presentation, 3 minute discussion)
Moderators: Shaun Wason, MD; Jared Bieniek, MD
26. Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain: A Double-Blinded Prospective Randomized Controlled Trial
Suprita Krishna, MD, Abigail Escobar, BS, Alejandro Abello, MD, Chris Mistretta, BS, Boris Gershman, MD, Peter Chang, MD, Andrew Wagner, MD, Ruslan Korets, MD, Kristen Schreiber, MD, Aria Olumi, MD, Heidi Rayala, MD.
Beth Israel Deaconess Medical Center, Boston, MA.
Suprita Krishna, MD, Abigail Escobar, BS, Alejandro Abello, MD, Chris Mistretta, BS, Boris Gershman, MD, Peter Chang, MD, Andrew Wagner, MD, Ruslan Korets, MD, Kristen Schreiber, MD, Aria Olumi, MD, Heidi Rayala, MD.
Beth Israel Deaconess Medical Center, Boston, MA.
27. Does a 5-Item Frailty Index Predict Surgical Outcomes of Endoscopic Surgical Management for Benign Prostatic Obstruction?
Muhieddine Labban, MD1, Nicola Frego, MD1, Jason Qian, MD1, David-Dan Nguyen, MPH1, Brittany D. Berk, MD1, Stuart R. Lipsirz, ScD1, Naeem Bhojani, MD2, Martin Kathrins, MD1, Quoc-Dien Trinh, MD1.
1Brigham and Women's Hospital, BOSTON, MA, USA, 2University of Montreal, Montreal, QC, Canada.
Muhieddine Labban, MD1, Nicola Frego, MD1, Jason Qian, MD1, David-Dan Nguyen, MPH1, Brittany D. Berk, MD1, Stuart R. Lipsirz, ScD1, Naeem Bhojani, MD2, Martin Kathrins, MD1, Quoc-Dien Trinh, MD1.
1Brigham and Women's Hospital, BOSTON, MA, USA, 2University of Montreal, Montreal, QC, Canada.
28. Same-Day Discharge After HoLEP: A Safety and Feasibility Study to Address Hospital Capacity Stressors in the COVID-19 Era
Adam Wiggins, MD, Jessica Mandeville, MD.
Lahey Hospital and Medical Center, Burlington, MA.
Adam Wiggins, MD, Jessica Mandeville, MD.
Lahey Hospital and Medical Center, Burlington, MA.
29. Lack of Diversification in BPH Procedures Among Urologists in New England
Anna Shlimak, BS Candidate, Class of 20241, Faizanahmed Munshi, MD2, Joshua Ray Tanzer, PhD3, Rebecca Ortiz, BA1, Elias Hyams, MD2.
1Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI, USA, 2Minimally Invasive Urology Institute, The Miriam Hospital; The Warren Alpert Medical School of Brown University, Providence, RI, USA, 3The Lifespan Biostatistics Epidemiology Research Design Core, Providence, RI, USA.
Anna Shlimak, BS Candidate, Class of 20241, Faizanahmed Munshi, MD2, Joshua Ray Tanzer, PhD3, Rebecca Ortiz, BA1, Elias Hyams, MD2.
1Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI, USA, 2Minimally Invasive Urology Institute, The Miriam Hospital; The Warren Alpert Medical School of Brown University, Providence, RI, USA, 3The Lifespan Biostatistics Epidemiology Research Design Core, Providence, RI, USA.
30. Antibiotic Prophylaxis Practice Patterns in Patients Undergoing Transurethral Resection or Vaporization of the Prostate with Preoperative Catheterization
Sai Allu, BS1, Martus Gn, MD1, Travis Wheeler, BS2, Rebecca Ortiz, BA2, Philip Caffery, PhD2, Christopher Tucci, MS1, Elias Hyams, MD1.
1Minimally Invasive Urology Institute, The Miriam Hospital; The Warren Alpert Medical School of Brown University, Providence, RI, USA, 2Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI, USA.
Sai Allu, BS1, Martus Gn, MD1, Travis Wheeler, BS2, Rebecca Ortiz, BA2, Philip Caffery, PhD2, Christopher Tucci, MS1, Elias Hyams, MD1.
1Minimally Invasive Urology Institute, The Miriam Hospital; The Warren Alpert Medical School of Brown University, Providence, RI, USA, 2Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI, USA.
31. Lower Rates of Continued and De Novo BPH Medication GE after the Prostatic Urethral Lift (PUL) Compared to TURP and PVP Demonstrated in US Healthcare Claims Analysis
Ronald Kaufman, MD1, Daniel Rukstalis, MD2, David Kaplan, MD3, Claus Roehrborn, MD4.
1Albany Medical College, Albany, NY, USA, 2Prisma Health USC Medical Group, Columbia, SC, USA, 3Academic Urology of Arizona, Litchfield Park, AZ, USA, 4UT Southwestern Medical Center, Dallas, TX, USA.
Ronald Kaufman, MD1, Daniel Rukstalis, MD2, David Kaplan, MD3, Claus Roehrborn, MD4.
1Albany Medical College, Albany, NY, USA, 2Prisma Health USC Medical Group, Columbia, SC, USA, 3Academic Urology of Arizona, Litchfield Park, AZ, USA, 4UT Southwestern Medical Center, Dallas, TX, USA.
33. Integration of Telehealth at Multidisciplinary Stone Clinic Increases Patient Adherence to Kidney Stone Prevention Visits
Sai Allu, BA1, Ji Whae Choi, BA1, Darshi Shah, BS2, Rebecca Ortiz, BA2, Philip Caffery, PhD2, Christopher Tucci, MS1, Jie Tang, MD1, Gyan Pareek, MD1, David Sobel, MD1.
1Minimally Invasive Urology Institute, The Miriam Hospital; Warren Alpert Medical School, Providence, RI, USA, 2Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI, USA.
Sai Allu, BA1, Ji Whae Choi, BA1, Darshi Shah, BS2, Rebecca Ortiz, BA2, Philip Caffery, PhD2, Christopher Tucci, MS1, Jie Tang, MD1, Gyan Pareek, MD1, David Sobel, MD1.
1Minimally Invasive Urology Institute, The Miriam Hospital; Warren Alpert Medical School, Providence, RI, USA, 2Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI, USA.
34. Current Findings Regarding Perioperative Complications in Benign Scrotal Surgery
Michael Rezaee, MD, MPH1, Amanda R. Swanton, MD, PhD2, Martin Gross, MD3.
1Brady Urological Institute, Johns Hopkins, Baltimore, MD, USA, 2Boston Medical Center, Boston, MA, USA, 3Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Michael Rezaee, MD, MPH1, Amanda R. Swanton, MD, PhD2, Martin Gross, MD3.
1Brady Urological Institute, Johns Hopkins, Baltimore, MD, USA, 2Boston Medical Center, Boston, MA, USA, 3Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
35. 7-Year Outcomes of Regionalized Care for Fournier's Gangrene at A Tertiary Care Center
Martus Gn, MD1, Rebecca Ortiz, BA2, Christopher Tucci, MS3, Kennon Miller, MD1, Madeline Cancian, MD1.
1The Warren Alpert Medical School of Brown University, Providence, RI, USA, 2Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI, USA, 3Minimally Invasive Urology Institute, The Miriam Hospital; The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Martus Gn, MD1, Rebecca Ortiz, BA2, Christopher Tucci, MS3, Kennon Miller, MD1, Madeline Cancian, MD1.
1The Warren Alpert Medical School of Brown University, Providence, RI, USA, 2Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI, USA, 3Minimally Invasive Urology Institute, The Miriam Hospital; The Warren Alpert Medical School of Brown University, Providence, RI, USA.
9:00 am - 10:30 am
CONCURRENT POSTER SESSION II
MA Room (3 minute presentation, 2 minute discussion)
Moderators: David Sobel, MD; Paula Bellin, MD
MA Room (3 minute presentation, 2 minute discussion)
Moderators: David Sobel, MD; Paula Bellin, MD
P12. Expression and Localization of miR-146a-5p and miR-142-3p in Urethral Submucosa of Patients with Lichen Sclerosus-Induced Urethral Stricture Disease
Aaron Perecman, MD1, Harjivan Kohli, MD1, Brandon Childs, MD1, Travis Sullivan, MA1, Myrtha Constant, BSc2, Eric Burks, MD2, Kimberly Rieger-Christ, PhD1, Alex Vanni, MD1.
1Lahey Clinic, Burlington, MA, USA, 2Boston Medical Center, Boston, MA, USA.
Aaron Perecman, MD1, Harjivan Kohli, MD1, Brandon Childs, MD1, Travis Sullivan, MA1, Myrtha Constant, BSc2, Eric Burks, MD2, Kimberly Rieger-Christ, PhD1, Alex Vanni, MD1.
1Lahey Clinic, Burlington, MA, USA, 2Boston Medical Center, Boston, MA, USA.
P13. The Absence of SRD5A2 Regulates the Heterotypic Cell-Cell Communication in Prostate
Christina Sharkey, MA1, Xingbo Long, MD2, Ra'ad Al-Faouri, MD1, Zongwei Wang, PhD1, Aria F. Olumi, MD1.
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2Sun Yat-sen University Cancer Center, Guangzhou, China.
Christina Sharkey, MA1, Xingbo Long, MD2, Ra'ad Al-Faouri, MD1, Zongwei Wang, PhD1, Aria F. Olumi, MD1.
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2Sun Yat-sen University Cancer Center, Guangzhou, China.
P14. Radiographic Progression in the Absence of Prostate-Specific Antigen (PSA) Progression in Patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Post hot analysis of ARCHES
Andrew J. Armstrong, MD, MSc1, Nicolas Mottet, MD, PhD2, Taro Iguchi, MD, PhD3, Russell Z. Szmulewitz, MD4, Jeffrey Holzbeierlein, MD5, Arnauld Villers, MD, PhD6, Antonio Alcaraz, MD, PhD7, Boris Alekseev, MD8, Neal D. Shore, MD9, Francisco Gomez-Veiga, MD, PhD10, Brad Rosbrook, MS11, Fabian Zohren, MD, PhD12, Ho-Jin Lee, PhD13, Gabriel Haas, MD13, Arnulf Stenzl, MD14, Arun A. Azad, MBBS, PhD15.
1Duke Cancer Institute, Center for Prostate & Urologic Cancers, Durham, NC, USA, 2University Hospital, St. Etienne, France, 3Kanazawa Medical University, Ishikawa, Japan, 4The University of Chicago, Chicago, IL, USA, 5The University of Kansas Medical Center, Kansas City, KS, USA, 6University Hospital Centre, Lille University, Lille, France, 7Hospital Clinic de Barcelona, Barcelona, Spain, 8Hertzen Moscow Cancer Research Institute, Moscow, Russian Federation, 9Carolina Urologic Research Center, Myrtle Beach, SC, USA, 10Complexo Hospitalario Universitario de A Coruña, Coruña, Spain, 11Pfizer Inc., San Diego, CA, USA, 12Pfizer Inc., New York, NY, USA, 13Astellas Pharma, Northbrook, IL, USA, 14University Hospital, Eberhard Karls University of Tübingen, Tübingen, Germany, 15Peter MacCallum Cancer Centre, Melbourne, Australia.
Andrew J. Armstrong, MD, MSc1, Nicolas Mottet, MD, PhD2, Taro Iguchi, MD, PhD3, Russell Z. Szmulewitz, MD4, Jeffrey Holzbeierlein, MD5, Arnauld Villers, MD, PhD6, Antonio Alcaraz, MD, PhD7, Boris Alekseev, MD8, Neal D. Shore, MD9, Francisco Gomez-Veiga, MD, PhD10, Brad Rosbrook, MS11, Fabian Zohren, MD, PhD12, Ho-Jin Lee, PhD13, Gabriel Haas, MD13, Arnulf Stenzl, MD14, Arun A. Azad, MBBS, PhD15.
1Duke Cancer Institute, Center for Prostate & Urologic Cancers, Durham, NC, USA, 2University Hospital, St. Etienne, France, 3Kanazawa Medical University, Ishikawa, Japan, 4The University of Chicago, Chicago, IL, USA, 5The University of Kansas Medical Center, Kansas City, KS, USA, 6University Hospital Centre, Lille University, Lille, France, 7Hospital Clinic de Barcelona, Barcelona, Spain, 8Hertzen Moscow Cancer Research Institute, Moscow, Russian Federation, 9Carolina Urologic Research Center, Myrtle Beach, SC, USA, 10Complexo Hospitalario Universitario de A Coruña, Coruña, Spain, 11Pfizer Inc., San Diego, CA, USA, 12Pfizer Inc., New York, NY, USA, 13Astellas Pharma, Northbrook, IL, USA, 14University Hospital, Eberhard Karls University of Tübingen, Tübingen, Germany, 15Peter MacCallum Cancer Centre, Melbourne, Australia.
P15. Apamin Inhibits Renal Fibrosis via Suppressing TGF-?1 and STAT3 Signaling in Unilateral Ureteral Obstruction (UUO) Mice and in Renal Fibroblast
Kwan-Kyu Park, Doctor of Medicine. Professor. College of medicine
Catholic University of Daegu, Daegu, Korea, Republic of.
Kwan-Kyu Park, Doctor of Medicine. Professor. College of medicine
Catholic University of Daegu, Daegu, Korea, Republic of.
P16. Alkaline Urine during Pregnancy is Associated with Increased Gastrointestinal Alkali Absorption
Eileen Brandes, MD1, John Asplin, MD2, Vernon Pais, MD1.
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 2Litholink, Itasca, IL, USA.
Eileen Brandes, MD1, John Asplin, MD2, Vernon Pais, MD1.
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 2Litholink, Itasca, IL, USA.
P17. Opioid Use and Associated Patient Satisfaction with Pain Control after Common Urologic Surgeries?
Clemens An, BS, Ethan D. Jones, MPH, Peter Callas, PhD, Kevan M. Sternberg, MD.
University of Vermont Medical Center, Burlington, VT, USA.
Clemens An, BS, Ethan D. Jones, MPH, Peter Callas, PhD, Kevan M. Sternberg, MD.
University of Vermont Medical Center, Burlington, VT, USA.
P18. Impact of COVID-19 on Emergency Department Use for Genitourinary Injury
Lulu Wei, BS, Isabelle Kaplan, MS, Lakshay Khosla, BA, Blaine Russ, BS, Lauren Fink, MD, Mahyar Kashani, MD, Andrew Winer, MD.
SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Lulu Wei, BS, Isabelle Kaplan, MS, Lakshay Khosla, BA, Blaine Russ, BS, Lauren Fink, MD, Mahyar Kashani, MD, Andrew Winer, MD.
SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
P19. Decreased Utilization of Low-Value Health Care Services during the COVID-19 Pandemic
Tracy Xuan Han, MD, MBA1, David-Dan Nguyen, MPH1, Peter Herzog, MPH1, Stuart Lipsitz, ScD1, Alexander P. Cole, MD1, Tony K. Choueiri, MD2, Quoc-Dien Trinh, MD, MBA1.
1Brigham and Women's Hospital, Boston, MA, USA, 2Dana-Farber Cancer Institute, Boston, MA, USA.
Tracy Xuan Han, MD, MBA1, David-Dan Nguyen, MPH1, Peter Herzog, MPH1, Stuart Lipsitz, ScD1, Alexander P. Cole, MD1, Tony K. Choueiri, MD2, Quoc-Dien Trinh, MD, MBA1.
1Brigham and Women's Hospital, Boston, MA, USA, 2Dana-Farber Cancer Institute, Boston, MA, USA.
P20. Associations Between First Year and Early-Year Costs in Pediatric Spina Bifida Patients - A Longitudinal Machine-Learning Based Analysis
Venkat M. Ramakrishnan, MD, PhD1, Michael Li, MBA.2, Carlos Estrada, MD, MBA3, Hsin Hsiao S. Wang, MD, MPH, MBAn3.
1Brigham and Women's Hospital, Boston, MA, USA, 2Massachusetts Institute of Technology, Boston, MA, USA, 3Boston Children's Hospital, Boston, MA, USA.
Venkat M. Ramakrishnan, MD, PhD1, Michael Li, MBA.2, Carlos Estrada, MD, MBA3, Hsin Hsiao S. Wang, MD, MPH, MBAn3.
1Brigham and Women's Hospital, Boston, MA, USA, 2Massachusetts Institute of Technology, Boston, MA, USA, 3Boston Children's Hospital, Boston, MA, USA.
P21. Clinical and Urodynamic Predictors of Hydronephrosis and Febrile UTIs in Neurogenic Bladder Children
Kenneth A. Softness, MD1, Ranveer Vasdev, MS2, Rachel Saunders, BA3, John C. Panagides, BS4, Carlos R. Estrada, Jr., MD, MBA3, Hsin-Hsiao Scott Wang, MD, MPH, MBAn3.
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2Medical School, University of Minnesota Twin Cities, Minneapolis, MN, USA, 3Boston Children's Hospital, Boston, MA, USA, 4Harvard Medical School, Boston, MA, USA.
Kenneth A. Softness, MD1, Ranveer Vasdev, MS2, Rachel Saunders, BA3, John C. Panagides, BS4, Carlos R. Estrada, Jr., MD, MBA3, Hsin-Hsiao Scott Wang, MD, MPH, MBAn3.
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2Medical School, University of Minnesota Twin Cities, Minneapolis, MN, USA, 3Boston Children's Hospital, Boston, MA, USA, 4Harvard Medical School, Boston, MA, USA.
P23. Urologic Clinical Trials are Under-Conducted in Low and Lower-middle Income Countries
Ankur Ushir Choksi, MD, Isaac Y. Kim, MD PhD MBA.
Yale School of Medicine, New Haven, CT, USA.
Ankur Ushir Choksi, MD, Isaac Y. Kim, MD PhD MBA.
Yale School of Medicine, New Haven, CT, USA.
P24. A Urology Fair Increases Medical Student Interest in Urology
Alan G. Perry, BA, Wesley R. Pate, MD, Mark H. Katz, MD, Shaun E. Wason, MD.
Department of Urology, Boston Medical Center, Boston, MA, USA.
Alan G. Perry, BA, Wesley R. Pate, MD, Mark H. Katz, MD, Shaun E. Wason, MD.
Department of Urology, Boston Medical Center, Boston, MA, USA.
P25. Separating Fact from Fiction: Misconceptions About Urology Amongst Medical Students
Priyanka Shindgikar, MS1, Lara S. MacLachlan, MD2.
1Tufts University School of Medicine, Boston, MA, USA, 2Lahey Hospital & Medical Center, Boston, MA, USA.
Priyanka Shindgikar, MS1, Lara S. MacLachlan, MD2.
1Tufts University School of Medicine, Boston, MA, USA, 2Lahey Hospital & Medical Center, Boston, MA, USA.
P27. Association of May-Thurner Syndrome with Semen Parameters Among Men with Varicocele
Catherine Gu, MD, Carol Benson, MD, Mary Frates, MD, Matthew Menard, MD, John Ernandez, MD, Brittany Berk, MD, Martin Kathrins, MD.
Brigham and Women's, Boston, MA, USA.
Catherine Gu, MD, Carol Benson, MD, Mary Frates, MD, Matthew Menard, MD, John Ernandez, MD, Brittany Berk, MD, Martin Kathrins, MD.
Brigham and Women's, Boston, MA, USA.
10:30 am - 11:15 am
COFFEE BREAK
Casco Bay
Casco Bay
11:15 am - 12:00 pm
Compensation Models in Urology
Raj S. Pruthi, MD MHA FACS
NH/VT Room
Raj S. Pruthi, MD MHA FACS
NH/VT Room
12:00 pm - 12:30 pm
Debate: Management of Apical Prolapse, What is Better: Vaginal Repair or Robotic Sacrocolpopexy
NH/VT Room
NH/VT Room
| Moderator: | Veronica Triaca, MD |
| Debaters: | Sanchita Bose, MD Maine Health, South Portland, ME Lara Maclachlan, MD Lahey Hospital & Medical Center, Burlington, MA |
12:30 pm - 12:45 pm
JU Update Section Representative to the Journal of Urology (Not for CME)
Martin Gross, MD
NH/VT Room
Martin Gross, MD
NH/VT Room
12:45 pm - 1:00 pm
Pickup Lunch
Ballroom Foyer
Ballroom Foyer
1:00 pm - 2:00 pm
A Treatment Option for Certain Patients With RCC in the Adjuvant Setting (Not for CME)
Lunch Symposium sponsored by Merck
NH/VT Room
Lunch Symposium sponsored by Merck
NH/VT Room
1:00 pm - 2:00 pm
ERLEADA® (apalutamide)—For the Treatment of Patients With: Metastatic Castration-Sensitive Prostate Cancer (mCSPC) (Not for CME)
Lunch Symposium sponsored by Janssen
CT/RI Room
Lunch Symposium sponsored by Janssen
CT/RI Room
2:00 pm - 2:30 pm
ANNUAL BUSINESS MEETING, Members Only
NH/VT Room
NH/VT Room
2:30 pm - 4:00 pm
SCIENTIFIC SESSION V: Infertility, Sexual Dysfunction and Men's Health
NH/VT Room (5 minute presentation, 3 minute discussion)
Moderators: Peter A. Holoch, MD; Martin Gross, MD
NH/VT Room (5 minute presentation, 3 minute discussion)
Moderators: Peter A. Holoch, MD; Martin Gross, MD
36. Previous Use of Intracavernosal Injections is Not Associated with Higher Rates of Intraoperative or Postoperative Inflatable Penile Prosthesis Complications: A Large Multi-institutional Analysis
James M. Jones, BA1, Martin Gross, MD2, David Barham, MD3, Daniel Swerdloff, MD4, Robert Andrianne, MD5, Georgios Hatzichristodolou, MD6, Aaron Lentz, MD7, Jeffrey Loh-Doyle, MD8, Koenraad van Renterghem, MD9, Sung Hun Park, MD10, Maxime Sempels, MD5, Jonathan N. Warner, MD11, Jay Simhan, MD4, Faysal Yafi, MD3.
1Geisel School of Medicine at Dartmouth, Hanover, NH, USA, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 3University of California Irvine Medical Center, Irvine, CA, USA, 4Einstein Healthcare Network, Philadelphia, PA, USA, 5University Hospital of Liège, Liège, Belgium, 6Krankenhaus Martha-Maria, Nürnberg, Germany, 7Duke Health, Durham, NC, USA, 8Keck School of Medicine, Los Angeles, CA, USA, 9UZ Leuven, Leuven, Belgium, 10Sewum Prosthetic Urology Center of Excellence, Seoul, Korea, Republic of, 11Mayo Clinic, Rochester, MN, USA.
James M. Jones, BA1, Martin Gross, MD2, David Barham, MD3, Daniel Swerdloff, MD4, Robert Andrianne, MD5, Georgios Hatzichristodolou, MD6, Aaron Lentz, MD7, Jeffrey Loh-Doyle, MD8, Koenraad van Renterghem, MD9, Sung Hun Park, MD10, Maxime Sempels, MD5, Jonathan N. Warner, MD11, Jay Simhan, MD4, Faysal Yafi, MD3.
1Geisel School of Medicine at Dartmouth, Hanover, NH, USA, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 3University of California Irvine Medical Center, Irvine, CA, USA, 4Einstein Healthcare Network, Philadelphia, PA, USA, 5University Hospital of Liège, Liège, Belgium, 6Krankenhaus Martha-Maria, Nürnberg, Germany, 7Duke Health, Durham, NC, USA, 8Keck School of Medicine, Los Angeles, CA, USA, 9UZ Leuven, Leuven, Belgium, 10Sewum Prosthetic Urology Center of Excellence, Seoul, Korea, Republic of, 11Mayo Clinic, Rochester, MN, USA.
37. Pharmacovigilance Analysis of Melanoma Adverse Events in Men Treated with Sildenafil for Erectile Dysfunction
Muhieddine Labban, MD1, David-Dan Nguyen, MPH1, Elio Adib, MD1, Kevin R Melnick, MD1, Alexander P. Cole, MD1, Stuart R. Lipsitz, ScD1, Toni K. Choueiri, MD2, Quoc-Dien Trinh, MD1.
1Brigham and Women's Hospital, BOSTON, MA, USA, 2Dana-Farber Cancer Institute, BOSTON, MA, USA.
Muhieddine Labban, MD1, David-Dan Nguyen, MPH1, Elio Adib, MD1, Kevin R Melnick, MD1, Alexander P. Cole, MD1, Stuart R. Lipsitz, ScD1, Toni K. Choueiri, MD2, Quoc-Dien Trinh, MD1.
1Brigham and Women's Hospital, BOSTON, MA, USA, 2Dana-Farber Cancer Institute, BOSTON, MA, USA.
39. Cardiometabolic Preventative Care in Men Presenting with Erectile Dysfunction
Leelakrishna Channa, BS1, Ilene Staff, PhD2, Tara McLaughlin, PhD2, Kevin Pinto, BS3, Laura Olivo Valentin, BS3, Jared Bieniek, MD3.
1UConn School of Medicine, Farmington, CT, USA, 2Hartford Hospital, Hartford, CT, USA, 3Tallwood Urology & Kidney Institute, Hartford HealthCare, Hartford, CT, USA.
Leelakrishna Channa, BS1, Ilene Staff, PhD2, Tara McLaughlin, PhD2, Kevin Pinto, BS3, Laura Olivo Valentin, BS3, Jared Bieniek, MD3.
1UConn School of Medicine, Farmington, CT, USA, 2Hartford Hospital, Hartford, CT, USA, 3Tallwood Urology & Kidney Institute, Hartford HealthCare, Hartford, CT, USA.
40. The Anatomic Diagnosis of Venous Leak Using CT Cavernosography
Jack Campbell, MD, Mary St. John, BS, Esther L. Finney, MD, Jonathan T. Xu, MD, Alex J. Vanni, MD, Andrew R. McCullough, MD.
Lahey Hospital and Medical Center, Burlington, MA.
Jack Campbell, MD, Mary St. John, BS, Esther L. Finney, MD, Jonathan T. Xu, MD, Alex J. Vanni, MD, Andrew R. McCullough, MD.
Lahey Hospital and Medical Center, Burlington, MA.
41. Predictors of Mental Health Concerns in a Men's Health Clinic
Leelakrishna Channa, BS1, Ilene Staff, PhD2, Tara McLaughlin, PhD2, Kevin Pinto, BS3, Laura Olivo Valentin, BS3, Jared Bieniek, MD3.
1UConn School of Medicine, Farmington, CT, USA, 2Hartford Hospital, Hartford, CT, USA, 3Tallwood Urology & Kidney Institute, Hartford HealthCare, Hartford, CT, USA.
Leelakrishna Channa, BS1, Ilene Staff, PhD2, Tara McLaughlin, PhD2, Kevin Pinto, BS3, Laura Olivo Valentin, BS3, Jared Bieniek, MD3.
1UConn School of Medicine, Farmington, CT, USA, 2Hartford Hospital, Hartford, CT, USA, 3Tallwood Urology & Kidney Institute, Hartford HealthCare, Hartford, CT, USA.
42. Adjuvant Dexamethasone and Dexmedetomidine in Bupivacaine Penile Nerve Block during Circumcision
Wesley R. Pate, MD, Christina S. Kottooran, MD, Ricardo M. Munarriz, MD.
Boston University Medical Center, Boston, MA.
Wesley R. Pate, MD, Christina S. Kottooran, MD, Ricardo M. Munarriz, MD.
Boston University Medical Center, Boston, MA.
43. Risky Business; The Use of Unregulated Phosphodiesterase Inhibitors in Healthcare Supplements
Rachel M. Greenberg, Joseph Caputo, Gabriella Avellino, Mark Sigman, Elias Hyams.
Rhode Island Hospital, Providence, RI.
Rachel M. Greenberg, Joseph Caputo, Gabriella Avellino, Mark Sigman, Elias Hyams.
Rhode Island Hospital, Providence, RI.
44. Multicenter Comparison of Single Dilation versus Sequential Dilation in Primary Inflatable Penile Prosthesis Placement
James M. Jones, BA1, Martin Gross, MD2, David Barham, MD3, Daniel Swerdloff, MD4, Robert Andrianne, MD5, Georgios Hatzichristodolou, MD6, Aaron Lentz, MD7, Jeffrey Loh-Doyle, MD8, Koenraad van Renterghem, MD9, Sung Hun Park, MD10, Maxime Sempels, MD5, Jonathan N. Warner, MD11, Jay Simhan, MD4, Faysal Yafi, MD3.
1Geisel School of Medicine at Dartmouth, Hanover, NH, USA, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 3University of California Irvine Medical Center, Irvine, CA, USA, 4Einstein Healthcare Network, Philadelphia, PA, USA, 5University Hospital of Liège, Liège, Belgium, 6Krankenhaus Martha-Maria, Nürnberg, Germany, 7Duke Health, Durham, NC, USA, 8Keck School of Medicine, Los Angeles, CA, USA, 9UZ Leuven, Leuven, Belgium, 10Sewum Prosthetic Urology Center of Excellence, Seoul, Korea, Republic of, 11Mayo Clinic, Rochester, MN, USA.
James M. Jones, BA1, Martin Gross, MD2, David Barham, MD3, Daniel Swerdloff, MD4, Robert Andrianne, MD5, Georgios Hatzichristodolou, MD6, Aaron Lentz, MD7, Jeffrey Loh-Doyle, MD8, Koenraad van Renterghem, MD9, Sung Hun Park, MD10, Maxime Sempels, MD5, Jonathan N. Warner, MD11, Jay Simhan, MD4, Faysal Yafi, MD3.
1Geisel School of Medicine at Dartmouth, Hanover, NH, USA, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 3University of California Irvine Medical Center, Irvine, CA, USA, 4Einstein Healthcare Network, Philadelphia, PA, USA, 5University Hospital of Liège, Liège, Belgium, 6Krankenhaus Martha-Maria, Nürnberg, Germany, 7Duke Health, Durham, NC, USA, 8Keck School of Medicine, Los Angeles, CA, USA, 9UZ Leuven, Leuven, Belgium, 10Sewum Prosthetic Urology Center of Excellence, Seoul, Korea, Republic of, 11Mayo Clinic, Rochester, MN, USA.
45. New Findings Regarding Independent Predictors of Poor Corporal Integrity in Penile Implant Recipients: A Multicenter International Investigation
James M. Jones, BA1, Martin Gross, MD2, David Barham, MD3, Daniel Swerdloff, MD4, Robert Andrianne, MD5, Georgios Hatzichristodolou, MD6, Aaron Lentz, MD7, Jeffrey Loh-Doyle, MD8, Koenraad van Renterghem, MD9, Sung Hun Park, MD10, Maxime Sempels, MD5, Jonathan N. Warner, MD11, Jay Simhan, MD4, Faysal Yafi, MD3.
1Geisel School of Medicine at Dartmouth, Hanover, NH, USA, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 3University of California Irvine Medical Center, Irvine, CA, USA, 4Einstein Healthcare Network, Philadelphia, PA, USA, 5University Hospital of Liège, Liège, Belgium, 6Krankenhaus Martha-Maria, Nürnberg, Germany, 7Duke Health, Durham, NC, USA, 8Keck School of Medicine, Los Angeles, CA, USA, 9UZ Leuven, Leuven, Belgium, 10Sewum Prosthetic Urology Center of Excellence, Seoul, Korea, Republic of, 11Mayo Clinic, Rochester, MN, USA.
James M. Jones, BA1, Martin Gross, MD2, David Barham, MD3, Daniel Swerdloff, MD4, Robert Andrianne, MD5, Georgios Hatzichristodolou, MD6, Aaron Lentz, MD7, Jeffrey Loh-Doyle, MD8, Koenraad van Renterghem, MD9, Sung Hun Park, MD10, Maxime Sempels, MD5, Jonathan N. Warner, MD11, Jay Simhan, MD4, Faysal Yafi, MD3.
1Geisel School of Medicine at Dartmouth, Hanover, NH, USA, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 3University of California Irvine Medical Center, Irvine, CA, USA, 4Einstein Healthcare Network, Philadelphia, PA, USA, 5University Hospital of Liège, Liège, Belgium, 6Krankenhaus Martha-Maria, Nürnberg, Germany, 7Duke Health, Durham, NC, USA, 8Keck School of Medicine, Los Angeles, CA, USA, 9UZ Leuven, Leuven, Belgium, 10Sewum Prosthetic Urology Center of Excellence, Seoul, Korea, Republic of, 11Mayo Clinic, Rochester, MN, USA.
4:00 pm - 4:30 pm
COFFEE BREAK, VISIT EXHIBITS
Casco Bay Hall
Casco Bay Hall
4:30 pm - 5:00 pm
Panel: Transperineal vs Transrectal Prostate Biopsy
NH/VT Room
NH/VT Room
| Moderator: | Preston C. Sprenkle, MD |
| Panelists: | Douglas M. Dahl, MD, FACS Massachusetts General Hospital, Boston, MA Benjamin T. Ristau, MD UConn Health, Farmington, CT |
5:00 pm - 6:00 pm
Women in Urology
NH/VT
Refreshments Provided
NH/VT
Refreshments Provided
| Facilitator: | Heidi Rayala, MD |
| Speakers: | Linda Ng, MD Boston Medical Center E. Ann Gormley, MD Dartmouth Hitchcock Medical Center, Lebanon, NH |
6:00 pm - 6:15 pm
Young Urologists Forum: Telemedicine
CT/RI
Julia Finkelstein, MD
Boston Children's Hospital, Boston, MA
CT/RI
Julia Finkelstein, MD
Boston Children's Hospital, Boston, MA
6:15 pm - 7:00 pm
Young Urologists Forum The Long Game in the Short Term: Early Career Promotion and Advancement
CT/RI
CT/RI
| Moderators: | Anne Dudley, MD; Stephanie Hanchuck, MD |
| Panelists: | Michael Leapman, MD Yale School of Medicine, New Haven, CT David Chalmers, MD Maine Medical Center, Portland, ME Gabriella Avellino, MD Brown University School of Medicine, Providence, RI |
6:30 pm - 7:30 pm
Attendee Reception in Exhibit Hall
Casco Bay
Casco Bay
SATURDAY, OCTOBER 1, 2022
7:00 am - 4:00 pm
REGISTRATION DESK
Lobby Foyer
Lobby Foyer
7:00 am - 4:00 pm
SPEAKER READY ROOM
Ballroom Foyer
Ballroom Foyer
7:00 am - 8:00 am
CONTINENTAL BREAKFAST
Casco Bay
Casco Bay
8:00 am - 12:00 pm
HOSPITALITY SUITE
York Room
York Room
7:30 am - 8:00 am
Panel: How to Build a Gender Affirmation Surgery Program? What you need to do GAS (psych, plastics, endocrine, etc.), Managements of Complications of GAS
NH/VT Room
NH/VT Room
| Moderator: | Ricardo M. Munarriz, MD |
| Panelists: | Rachel A. Moses, MD Dartmouth Hitchcock Medical Center, Lebanon, NH Khushabu Kasabwala, MD Lahey Hospital and Medical Center, Burlington, MA |
8:00 am - 10:00 am
CONCURRENT AUA COURSE: A Guidelines Based Approach to the Management of Recurrent UTI's
CT/RI Room
Toby C. Chai, MD
Boston University, Boston, MA
CT/RI Room
Toby C. Chai, MD
Boston University, Boston, MA
8:00 am - 8:30 am
STATE OF THE ART LECTURE II: Cytoreductive Nephrectomy vs Upfront Systemic Therapy in met RCC
NH/VT Room
Michael L. Blute, MD
Massachusetts General Hospital, Boston, MA
NH/VT Room
Michael L. Blute, MD
Massachusetts General Hospital, Boston, MA
8:30 am - 10:00 am
SCIENTIFIC SESSION VI: Bladder/Kidney Cancer
NH/VT Room (5 minute presentation, 3 minute discussion)
Moderators: Scott Perrapato, DO; S. Machele Donat, MD; Adam Feldman, MD
NH/VT Room (5 minute presentation, 3 minute discussion)
Moderators: Scott Perrapato, DO; S. Machele Donat, MD; Adam Feldman, MD
46. Patient Reported Outcome Measures Following Hyperbaric Oxygen Therapy for Radiation Cystitis: Updated Results from the Multicenter Registry for Hyperbaric Oxygen Therapy Consortium
Rachel Moses, MD1, Eileen Brandes, MD1, Devin Cowan, BS2, Nicole Harlan, MD1, Judy Rees, PhD, MPH3, William Bihrle, III, MD1, Jay Buckey, Jr., MD1.
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 2Dartmouth College, Hanover, NH, USA, 3Dartmouth Geisel School of Medicine, Hanover, NH, USA.
Rachel Moses, MD1, Eileen Brandes, MD1, Devin Cowan, BS2, Nicole Harlan, MD1, Judy Rees, PhD, MPH3, William Bihrle, III, MD1, Jay Buckey, Jr., MD1.
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 2Dartmouth College, Hanover, NH, USA, 3Dartmouth Geisel School of Medicine, Hanover, NH, USA.
47. Urinary Comprehensive Genomic Profiling Predicts Clinical Recurrence in Patients Undergoing Surveillance for Urothelial Carcinoma
Jason Lee, MD1, Vincent T. Bicocca, PhD2, Vincent Caruso, MS2, Brian C. Mazzarella, MD2, Kevin G. Phillips, PhD2, Trevor G. Levin, PhD2, Adam S. Feldman, MD, MPH1, Keyan Salari, MD, PhD1.
1Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA, 2Convergent Genomics, Inc., San Francisco, CA, USA.
Jason Lee, MD1, Vincent T. Bicocca, PhD2, Vincent Caruso, MS2, Brian C. Mazzarella, MD2, Kevin G. Phillips, PhD2, Trevor G. Levin, PhD2, Adam S. Feldman, MD, MPH1, Keyan Salari, MD, PhD1.
1Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA, 2Convergent Genomics, Inc., San Francisco, CA, USA.
48. The Association of Baseline Frailty with Survival Among Older Adults Undergoing Radical Cystectomy for Bladder Cancer
John Ernandez, BA1, Sumedh Kaul, MS2, Aaron Fleishman, MPH2, Ruslan Korets, MD3, Peter Chang, MD, MPH3, Andrew Wagner, MD3, Simon Kim, MD4, Joaquim Bellmunt, MD, PhD5, Nima Aghdam, MD6, Aria Olumi, MD3, Dae Kim, MD, MPH, ScD7, Boris Gershman, MD3.
1Harvard Medical School, Boston, MA, USA, 2Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA, 3Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA, 4Division of Urology, University of Colorado Anschutz Medical Center, Aurora, CO, USA, 5Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA, 6Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA, 7Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, MA; Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
John Ernandez, BA1, Sumedh Kaul, MS2, Aaron Fleishman, MPH2, Ruslan Korets, MD3, Peter Chang, MD, MPH3, Andrew Wagner, MD3, Simon Kim, MD4, Joaquim Bellmunt, MD, PhD5, Nima Aghdam, MD6, Aria Olumi, MD3, Dae Kim, MD, MPH, ScD7, Boris Gershman, MD3.
1Harvard Medical School, Boston, MA, USA, 2Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA, 3Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA, 4Division of Urology, University of Colorado Anschutz Medical Center, Aurora, CO, USA, 5Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA, 6Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA, 7Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, MA; Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
49. Baseline Frailty and Perioperative Outcomes in Older Adults Undergoing Radical Cystectomy for Bladder Cancer
John Ernandez, BA1, Sumedh Kaul, MS2, Aaron Fleishman, MPH2, Ruslan Korets, MD3, Peter Chang, MD, MPH3, Andrew Wagner, MD3, Simon Kim, MD4, Joaquim Bellmunt, MD, PhD5, Nima Aghdam, MD6, Aria Olumi, MD3, Dae Kim, MD, MPH, ScD7, Boris Gershman, MD3.
1Harvard Medical School, Boston, MA, USA, 2Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA, 3Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA, 4Division of Urology, University of Colorado Anschutz Medical Center, Aurora, CO, USA, 5Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA, 6Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA, 7Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, MA; Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
John Ernandez, BA1, Sumedh Kaul, MS2, Aaron Fleishman, MPH2, Ruslan Korets, MD3, Peter Chang, MD, MPH3, Andrew Wagner, MD3, Simon Kim, MD4, Joaquim Bellmunt, MD, PhD5, Nima Aghdam, MD6, Aria Olumi, MD3, Dae Kim, MD, MPH, ScD7, Boris Gershman, MD3.
1Harvard Medical School, Boston, MA, USA, 2Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA, 3Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA, 4Division of Urology, University of Colorado Anschutz Medical Center, Aurora, CO, USA, 5Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA, 6Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA, 7Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, MA; Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
50. Radical Cystectomy Outcomes Based on Travel Distance in a Rural State
Randie E. White, MD, Joshua A. Linscott, MD, PhD, Moritz Hansen, MD, Matthew Hayn, MD, Stephen T. Ryan, MD, Jesse D. Sammon, DO.
Maine Medical Center, Portland, ME.
Randie E. White, MD, Joshua A. Linscott, MD, PhD, Moritz Hansen, MD, Matthew Hayn, MD, Stephen T. Ryan, MD, Jesse D. Sammon, DO.
Maine Medical Center, Portland, ME.
51. Comparison Between Cytologic Processing Upper Urinary Tract Microbiopsies and Conventional Processing of Surgical Biopsies in Diagnosing Upper Tract Urothelial Carcinoma (UTUC)
Taylor Harris, BS, Zhenwei Zhang, MD,PhD, MaryPat Scott, BA, Andrew Fischer, MD, Jennifer Yates, MD.
University of Massachusetts, Worcester, MA.
Taylor Harris, BS, Zhenwei Zhang, MD,PhD, MaryPat Scott, BA, Andrew Fischer, MD, Jennifer Yates, MD.
University of Massachusetts, Worcester, MA.
53. Ileal Conduit versus Continent Urinary Diversion in Radical Cystectomy: An Analysis of 30-day NSQIP Outcomes
Michael Rezaee, MD, MPH1, William Bihrle, MD2, Florian R. Schroeck, MD, MS2, Johnd D. Seigne, MB2.
1Johns Hopkins Medicine, Baltimore, MD, USA, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Michael Rezaee, MD, MPH1, William Bihrle, MD2, Florian R. Schroeck, MD, MS2, Johnd D. Seigne, MB2.
1Johns Hopkins Medicine, Baltimore, MD, USA, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
54. Cumulative Impact of Serial Partial Nephrectomy for the Treatment of Recurrent Renal Masses
Maria B. Antony, BSc, Zach Kozel, MD, Nikhil Gopal, MD, Lauren Loebach, BSc, Sandeep Gurram, MD, W. Marston Linehan, MD, Mark W. Ball, MD.
National Cancer Institute, Urologic Oncology Branch, Bethesda, MD.
Maria B. Antony, BSc, Zach Kozel, MD, Nikhil Gopal, MD, Lauren Loebach, BSc, Sandeep Gurram, MD, W. Marston Linehan, MD, Mark W. Ball, MD.
National Cancer Institute, Urologic Oncology Branch, Bethesda, MD.
55. Surgical Outcomes after Cytoreductive Nephrectomy following Neoadjuvant Immunotherapy for Metastatic Renal Cell Carcinoma
Vincent D. D'Andrea, MD1, Steven L. Chang, MD MS1, Matthew Mossanen, MD MPH1, Timothy N. Clinton, MD1, Kendrick Yim, MD1, Graeme S. Steele, MD1, Mark A. Preston, MD MPH1, Grant L. Steele, BA2, Filipe L.F. Carvalho, MD PhD1.
1Brigham & Women's Hospital, Boston, MA, USA, 2Harvard Medical School, Boston, MA, USA.
Vincent D. D'Andrea, MD1, Steven L. Chang, MD MS1, Matthew Mossanen, MD MPH1, Timothy N. Clinton, MD1, Kendrick Yim, MD1, Graeme S. Steele, MD1, Mark A. Preston, MD MPH1, Grant L. Steele, BA2, Filipe L.F. Carvalho, MD PhD1.
1Brigham & Women's Hospital, Boston, MA, USA, 2Harvard Medical School, Boston, MA, USA.
10:00 am - 10:30 am
COFFEE BREAK
Ballroom Foyer
Ballroom Foyer
10:30 am - 10:45 am
Bladder Cancer, a Patient's Perspective
NH/VT Room
Introduction: John D. Seigne, MD, NE-AUA PresidentPatient's Perspective: David Edwards
NH/VT Room
Introduction: John D. Seigne, MD, NE-AUA President
10:45 am - 11:30 am
LEADBETTER LECTURE: Standardizing How We Evaluate and Report Surgical Outcomes can Improve Patient Outcomes
NH/VT Room
S. Machele Donat, MD, FACS
Memorial Sloan Kettering Cancer Center, New York, NY
NH/VT Room
S. Machele Donat, MD, FACS
Memorial Sloan Kettering Cancer Center, New York, NY
11:00 am - 1:00 PM
RESIDENT QUIZ BOWL
CT/RI
Moderator: Adam B. Hittelman, MD
CT/RI
Moderator: Adam B. Hittelman, MD
11:30 am - 12:30 pm
SCIENTIFIC SESSION VII: Prostate Cancer II
NH/VT Room (5 minute presentation, 3 minute discussion)
Moderators: Jesse Sammon, MD; Joseph F. Renzulli, MD
NH/VT Room (5 minute presentation, 3 minute discussion)
Moderators: Jesse Sammon, MD; Joseph F. Renzulli, MD
56. Feasibility of Nonlinear Microscopy Technique for Evaluating Prostatectomy Margins in Real Time
May Jean Counsilman, MD1, Utsav Bansal, MD1, Yuchen Liu, BS, BA1, Yue Sun, MD1, Seymour Rosen, MD1, Lucas Cahill, PhD2, Tadayuki Yoshitake, PhD2, James Fujimoto, PhD2, Yubo Wu, DO1, Catrina Crociani, MPH1, Allison Kleeman, BS1, Jeffrey Sun, BS1, Timothy Weber, PhD2, Sagar Doshi, BS2, Peter Chang, MD, MPH1, Andrew A. Wagner, MD1.
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2Massachusetts Institute of Technology, Cambridge, MA, USA.
May Jean Counsilman, MD1, Utsav Bansal, MD1, Yuchen Liu, BS, BA1, Yue Sun, MD1, Seymour Rosen, MD1, Lucas Cahill, PhD2, Tadayuki Yoshitake, PhD2, James Fujimoto, PhD2, Yubo Wu, DO1, Catrina Crociani, MPH1, Allison Kleeman, BS1, Jeffrey Sun, BS1, Timothy Weber, PhD2, Sagar Doshi, BS2, Peter Chang, MD, MPH1, Andrew A. Wagner, MD1.
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2Massachusetts Institute of Technology, Cambridge, MA, USA.
57. Intraprostatic Ethanol Injection Using a Porous Needle in an Acute and Chronic Canine Study, Heart-Beating Cadaveric Organ Donors, and a Murine Xenograft Model of Human Prostate Cancer
Kevin C. DiBona, BS1, Jan Svihra, Jr., MD2, Megan N. Eubank, BS1, Jan Strnadel, BS3, Benjamin J. King, MD1, Mark K. Plante, MD1, Jan Luptak, MD2, Mads Hvid Aaberg Poulsen, MD4, Masatoshi Kida, MD5, Eduard Baco, MD6, Jan Svihra, MD2, Peter Zvara, MD7.
1Department of Surgery, Larner College of Medicine, University of Vermont Medical Center, Burlington, VT, USA, 2Department of Urology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Bratislava, Slovakia, 3Biomedical Center, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Bratislava, Slovakia, 4Department of Urology, Odense University Hospital, Odense, Denmark, 5Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, VT, USA, 6Department of Urology, Oslo University Hospital, Oslo, Norway, 7Biomedical Laboratory and Research Unit of Urology, University of Southern Denmark, Odense, Denmark.
Kevin C. DiBona, BS1, Jan Svihra, Jr., MD2, Megan N. Eubank, BS1, Jan Strnadel, BS3, Benjamin J. King, MD1, Mark K. Plante, MD1, Jan Luptak, MD2, Mads Hvid Aaberg Poulsen, MD4, Masatoshi Kida, MD5, Eduard Baco, MD6, Jan Svihra, MD2, Peter Zvara, MD7.
1Department of Surgery, Larner College of Medicine, University of Vermont Medical Center, Burlington, VT, USA, 2Department of Urology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Bratislava, Slovakia, 3Biomedical Center, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Bratislava, Slovakia, 4Department of Urology, Odense University Hospital, Odense, Denmark, 5Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, VT, USA, 6Department of Urology, Oslo University Hospital, Oslo, Norway, 7Biomedical Laboratory and Research Unit of Urology, University of Southern Denmark, Odense, Denmark.
58. Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy
William Martin, BS1, Johnathan Drevik, MD, MS2, Christian Schaufler, MD3, Ryan Daigle, BS1, Serge Ginzburg, MD2, Alexander Kutikov, MD, FACS4, Carl Gjertson, MD1, Peter Albertsen, MD1, Benjamin T. Ristau, MD, MHA1.
1UConn Health, Farmington, CT, USA, 2Einstein Healthcare Network, Philadelphia, PA, USA, 3Beth Israel Lahey Health, Boston, MA, USA, 4Temple Health, Philadelphia, PA, USA.
William Martin, BS1, Johnathan Drevik, MD, MS2, Christian Schaufler, MD3, Ryan Daigle, BS1, Serge Ginzburg, MD2, Alexander Kutikov, MD, FACS4, Carl Gjertson, MD1, Peter Albertsen, MD1, Benjamin T. Ristau, MD, MHA1.
1UConn Health, Farmington, CT, USA, 2Einstein Healthcare Network, Philadelphia, PA, USA, 3Beth Israel Lahey Health, Boston, MA, USA, 4Temple Health, Philadelphia, PA, USA.
59. Disparities in Prostate Cancer Specific Mortality between Black and White Men According with the Type of Definitive Treatment
Nicola Frego, MD, Muhieddine Labban, MD, Mara Koelker, MD, Khalid Alkhatib, MD, Stuart R. Lipsitz, ScD, Quoc-Dien Trinh, MD, Alexander P. Cole, MD.
Brigham and Women's hospital, Boston, MA, USA.
Nicola Frego, MD, Muhieddine Labban, MD, Mara Koelker, MD, Khalid Alkhatib, MD, Stuart R. Lipsitz, ScD, Quoc-Dien Trinh, MD, Alexander P. Cole, MD.
Brigham and Women's hospital, Boston, MA, USA.
60. Safety and Pathologic Findings of Robotically Assisted Super-Extended Pelvic Lymph Node Dissection for Prostate Cancer
Ryan Daigle, BS, Tara McLaughlin, PhD, Ilene Staff, PhD, Joseph Tortora, MS, Akshay Gangakhedkar, BS, Joseph Wagner, MD.
Hartford Hospital, Hartford, CT.
Ryan Daigle, BS, Tara McLaughlin, PhD, Ilene Staff, PhD, Joseph Tortora, MS, Akshay Gangakhedkar, BS, Joseph Wagner, MD.
Hartford Hospital, Hartford, CT.
61. Establishment and Evaluation of a Multidisciplinary Virtual Prostate Cancer Clinic
Ryan Dorin, MD, Tara McLaughlin, PhD, Ashley Bodamer, MPA, Suzanne Carrier, APRN, Ilene Staff, PhD.
Hartford Hospital, Hartford, CT.
Ryan Dorin, MD, Tara McLaughlin, PhD, Ashley Bodamer, MPA, Suzanne Carrier, APRN, Ilene Staff, PhD.
Hartford Hospital, Hartford, CT.
62. Outpatient Single Port Robotic Radical Prostatectomy: Outcomes of 157 patients and Analysis of Learning Curve
Juliana E. Kim, AB1, Isaac E. Kim, Jr., ScB2, Saum Ghodoussipour, MD3, Moses M. Kim, MD, PhD4, Isaac Yi Kim, MD, PhD, MBA5.
1Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, The State of New Jersey, New Brunswick, NJ, USA, 2Alpert Medical School of Brown University, Providence, RI, USA, 3Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, The State of New Jersey, New Brunswick, NB, USA, 4Orange County Urology Associates, Irvine, CA, USA, 5Department of Urology, Yale School of Medicine, New Haven, CT, USA.
Juliana E. Kim, AB1, Isaac E. Kim, Jr., ScB2, Saum Ghodoussipour, MD3, Moses M. Kim, MD, PhD4, Isaac Yi Kim, MD, PhD, MBA5.
1Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, The State of New Jersey, New Brunswick, NJ, USA, 2Alpert Medical School of Brown University, Providence, RI, USA, 3Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, The State of New Jersey, New Brunswick, NB, USA, 4Orange County Urology Associates, Irvine, CA, USA, 5Department of Urology, Yale School of Medicine, New Haven, CT, USA.
12:26 PM - 12:35 PM
AMERICAN BOARD OF UROLOGY UPDATE
NH/VT
E. Ann Gormley, MD
Dartmouth Hitchcock Medical Center, Lebanon, NH
NH/VT
E. Ann Gormley, MD
Dartmouth Hitchcock Medical Center, Lebanon, NH
12:30 pm - 2:00 pm
NETWORKING LUNCH (Not for CME)
Casco Bay
Casco Bay
2:00 pm - 3:00 pm
APP Program: Drugs and Bugs
NH/VT Room
NH/VT Room
| Speakers: | Susan Palmer, PA Lahey Hospital and Medical Center, Burlington, MA Carol Daugherty, ANP Beth Israel Deaconess Medical Center, Boston, MA Erin Santos, PA-C Maine Health, South Portland, ME |
3:00 pm - 4:00 pm
APP Program: Understanding Urodynamics
NH/VT
NH/VT
| Speakers: | E. Ann Gormley, MD Dartmouth Hitchcock Medical Center, Lebanon, NH |
2:00 pm - 4:00 pm
Surgical Management of SUI Simulation (Not for CME)
Sponsored by Boston Scientific and Axonics
CT/RI Room
Sponsored by Boston Scientific and Axonics
CT/RI Room
2:00 pm - 4:00 pm
Transperineal Prostate Biopsy Simulation (Not for CME)
Sponsored by Koelis
Oxford/Somerset
Sponsored by Koelis
Oxford/Somerset
4:00 pm
ADJOURN
6:30 pm - 9:00 pm
PRESIDENT'S RECEPTION
Shipyard Brewery
Shipyard Brewery